2023 ESC Guidelines on ACS: what is new in antithrombotic therapy?

被引：2
|
作者：
Galli, Mattia [1 ]
Andreotti, Felicita [2 ,3 ]
Sabouret, Pierre [4 ]
Gragnano, Felice [5 ,6 ]
机构：
[1] Maria Cecilia Hosp, GVM Care & Res, I-48033 Cotignola, Italy
[2] Fdn Policlin Univ A Gemelli IRCCS, Dept Cardiovasc Sci, I-00168 Rome, Italy
[3] Catholic Univ, Med Sch, I-00168 Rome, Italy
[4] Sorbonne Univ, ACTION Study Grp, Inst Cardiol, Hop Pitie Salpetriere, I-75013 Paris, France
[5] Univ Campania Luigi Vanvitelli, Dept Translat Med Sci, I-81055 Caserta, Italy
[6] AORN St Anna & San Sebastiano, Div Clin Cardiol, I-81100 Caserta, Italy
来源：
EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY | 2023年 / 9卷 / 07期
关键词：
MONOTHERAPY;
D O I：
10.1093/ehjcvp/pvad065
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：595 / 596
页数：2
相关论文
共 50 条
  • [21] ESC-Leitlinien 2023 zum Management der EndokarditisWas ist neu?ESC guidelines 2023 on the management of endocarditisWhat is new?
    Suzanne de Waha
    Steffen Desch
    Roland Tilz
    Julia Vogler
    Madlen Uhlemann
    Mateo Marín-Cuartas
    Matthias Raschpichler
    Michael Borger
    Herz, 2024, 49 : 33 - 42
  • [22] Antithrombotic Therapy for ACS in Elderly Patients
    Roule, Vincent
    Blanchart, Katrien
    Humbert, Xavier
    Legallois, Damien
    Lemaitre, Adrien
    Milliez, Paul
    Beygui, Farzin
    Alexandre, Joachim
    CARDIOVASCULAR DRUGS AND THERAPY, 2017, 31 (5-6) : 609 - 618
  • [23] Antithrombotic Therapy for ACS in Elderly Patients
    Vincent Roule
    Katrien Blanchart
    Xavier Humbert
    Damien Legallois
    Adrien Lemaitre
    Paul Milliez
    Farzin Beygui
    Joachim Alexandre
    Cardiovascular Drugs and Therapy, 2017, 31 : 609 - 618
  • [24] Antithrombotic management in patients with atrial fibrillation undergoing stent implantation: what is the impact of the ESC guidelines adherence?
    Fauchier, L.
    Ancedy, Y.
    Lecoq, C.
    Saint Etienne, C.
    Ivanes, F.
    Babuty, D.
    Angoulvant, D.
    Lip, G. Y. H.
    EUROPEAN HEART JOURNAL, 2015, 36 : 1084 - 1084
  • [25] Heart failure: update of the ESC 2023 guidelines
    Bauersachs, Johann
    Soltani, Samira
    HERZ, 2024, 49 (01) : 19 - 21
  • [26] Comments on the 2023 guidelines of the ESC on infectious endocarditis
    de Waha, Suzanne
    Abdel-Wahab, Mohamed
    Al-Nawas, Bilal
    Buerke, Michael
    Flachskampf, Frank A.
    Huntgeburth, Michael
    Mangner, Norman
    Plicht, Bjoern
    Tilz, Roland
    Frantz, Stefan
    Borger, Michael A.
    KARDIOLOGIE, 2024, 18 (06): : 447 - 457
  • [27] Comments on the 2023 guidelines of the ESC on management of cardiomyopathies
    Meder, Benjamin
    Eckardt, Lars
    Falk, Volkmar
    Klaassen, Sabine
    Klingenheben, Thomas
    Knebel, Fabian
    Schulze-Bahr, Eric
    Schulz-Menger, Jeanette
    KARDIOLOGIE, 2024, 18 (03): : 241 - 255
  • [28] Comments on the 2023 ESC guidelines for the management of endocarditis
    Vivas, David
    San Roman, Alberto
    Anguita, Manuel
    Fernandez-Hidalgo, Nuria
    Fernandez-Lozano, Ignacio
    Gonzalez-Juanatey, Carlos
    Gonzalez, Ariana
    Parellada, Marta
    Quintana, Eduard
    Ferreiro, Jose Luis
    Avanzas, Pablo
    Andrea, Rut
    Boraita, Araceli
    Calvo, David
    Campuzano, Raquel
    Delgado, Victoria
    Dos Subira, Laura
    Doblas, Juan Jose Gomez
    Momblan, Maria Antonia Martinez
    Mazon, Pilar
    Figal, Domingo Pascual
    Sanchis, Juan
    Hernandez, Jose Maria de la Torre
    Vivas, David
    REVISTA ESPANOLA DE CARDIOLOGIA, 2024, 77 (03): : 191 - 195
  • [29] Comments on the 2023 ESC guidelines for the management of cardiomyopathies
    Argulles, E. Villacorta
    Dos Subira, L.
    REVISTA ESPANOLA DE CARDIOLOGIA, 2024, 77 (04): : 285 - 289
  • [30] Comments on the new ESC guidelines on pacemaker and cardiac resynchronization therapy
    Israel, C. W.
    Baensch, D.
    Breithardt, O.
    Butter, C.
    Klingenheben, T.
    Kolb, C.
    Lemke, B.
    Wiegand, U.
    Nowak, B.
    KARDIOLOGE, 2015, 9 (01): : 35 - 45
12345